This content is machine translated IBDmatters - Synergy effects for IBD pathways How combination therapies lead to better treatment results Inflammatory bowel diseases ( IBD) are complex and multifactorial diseases that require a differentiated and evolving treatment approach. When monotherapies reach their limits, the need for combination strategies grows. The...… CME-Test
View Post 9 min This content is machine translated Hepatocellular carcinoma Systemic treatment of HCC – combination therapies on the rise Hepatocellular carcinoma (HCC) is the most common primary liver cell tumor and presents a challenge in systemic treatment with its intrinsic resistance to classical chemotherapeutic agents. The responsible clinician must… CME-Test
